J Korean Ophthalmol Soc > Volume 52(5); 2011 > Article
Journal of the Korean Ophthalmological Society 2011;52(5):574-581.
DOI: https://doi.org/10.3341/jkos.2011.52.5.574    Published online May 15, 2011.
The Long-Term Observation of Intraocular Pressure after Intravitreal Injections of Bevacizumab, Triamcinolone, and Combination of Both.
Yong Woon Shin, Hee Yoon Cho, Yoon Jung Lee, Min Chul Seong
Department of Ophthalmology, Hanyang University College of Medicine, Seoul, Korea. goddns76@hanmail.net
유리체강 내 베바시주맙, 트리암시놀론 및 혼합약제 주입 후 장기간 안압변동 관찰
신용운⋅조희윤⋅이윤정⋅성민철
Department of Ophthalmology, Hanyang University College of Medicine, Seoul, Korea
Abstract
PURPOSE
The present study investigates the onset and frequency of increased intraocular pressure (IOP) after injections of intravitreal Bevacizumab, Triamcinolone, and a combination of both drugs. METHODS: Patients were classified into three groups: Bevacizumab group (group A), Triamcinolone group (group B), and combined drug group (group C), irrespective of the underlying causes. The IOP was measured 30 minutes prior to followed by one day, one week, one month, two months, three months, six months, and one year after injection. The measured IOP at each time point was compared with the pre-injection IOP and the differences in IOP among the three groups were statistically analyzed. The relationships between various factors possible of increasing IOP were also analyzed. RESULTS: A total of 259 subjects were enrolled in the present study. An IOP increase of more than 5 mm Hg was observed in 25 eyes (15%) in group A, 34 eyes (40%) in group B, and 40 eyes (50%) in group C. There was no statistically significant mean IOP change after injection in group A, but in groups B and C there was an increase in mean IOP up until two and three months after injection, respectively. However, eyes in group A with a history of glaucoma showed statistically significant increases in IOP. CONCLUSIONS: The onsets and frequencies of increased IOP were different with the different drugs. Proper follow-up for increased IOP after injection is necessary based on the type of drug used.
Key Words: Bevacizumab;Combined drugs;Intraocular pressure;Intravitreal injection;Triamcinolone


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next